Gastroenterology

SRI possesses significant expertise in gastroenterology, with extensive research experience in key gastroenterological indications such as inflammatory bowel diseases, such as Crohn’s Disease and Ulcerative Colitis, irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), liver diseases, and other digestive disorders. Our research portfolio covers both US and global markets, addressing a wide range of business questions related to these conditions through physician and patient studies.

SRI’s research capabilities include new product demand estimation, indication, and formulation research; market overview and usage studies; and regular monthly or quarterly tracking studies. We support product launches with conjoint studies, map patient journeys and market landscapes, and perform segmentation studies using both qualitative and quantitative methods, in addition to Big Data Analytics in the US. Additionally, SRI evaluates omnichannel activity recall, message effectiveness, and market size estimation, providing comprehensive insights to clients in the gastroenterology therapeutic area.